![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study
Publisher: Karger
E-ISSN: 1423-0232|80|3-4|238-246
ISSN: 0030-2414
Source: Oncology, Vol.80, Iss.3-4, 2011-07, pp. : 238-246
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)